Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Hogness, C.
space
 arrow  PubMed                        
space

LETTER

Risks for Bleeding in Patients with Pulmonary Embolism Treated with Thrombolytic Agents

right arrow Chris Hogness

15 April 1995 | Volume 122 Issue 8 | Pages 630-632


TO THE EDITOR:

Stein and colleagues [1] used data on myocardial infarction to make an important statistical argument that bleeding caused by thrombolytic agents that were given for noninvasively diagnosed pulmonary embolism would be less than the bleeding after a diagnosis established by an invasive (angiographic) procedure. However, they do not adequately discuss the potential problems of comparing apples with oranges.

The risk ratio for bleeding events when invasive compared with noninvasive methods are used after myocardial infarction might be different than the same ratio after pulmonary embolism. Venous pressures may be higher after a massive pulmonary embolus, which could increase the risk for bleeding from cannulation of a central vein relatively more than it would increase the risk after cannulation in patients with myocardial infarction. The underlying illness associated with pulmonary embolism, including not only recent surgery (which the authors note) but also underlying malignancy, may increase the risk for bleeding with either diagnostic approach and thus may decrease the relative difference. The authors fail to discuss the implications of such problems on their underlying methods.


REFERENCE
space
up arrowTop
dotREFERENCE

1. Stein PD, Hull RD, Raskob G. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management. Ann Intern Med. 1994; 121:313-7.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Hogness, C.
space
 arrow  PubMed                        
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online